Literature DB >> 25398276

Curcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells.

Agnieszka Wolnicka-Glubisz1, Katarzyna Nogal, Andrzej Żądło, Przemysław M Płonka.   

Abstract

Melanin, the basic skin pigment present also in the majority of melanomas, has a huge impact on the efficiency of photodynamic, radio- or chemotherapies of melanoma. Moreover, the melanoma cells produce more melanin than normal melanocytes in adjacent skin do. Thus, attention has been paid to natural agents that are safe and effective in suppression of melanogenesis. B16F10 cells were studied by electron paramagnetic resonance (EPR) spectroscopy. The cells were cultured for 24-72 h in RPMI or DMEM with or without curcumin. The results confirmed that curcumin has no significant effect on B16F10 cells viability at concentrations of 1-10 µM. Curcumin at concentration of 10 µM significantly inhibited their proliferation and stimulated differentiation. We have not stimulated melanogenesis hormonally but we found a strong increase in melanogenesis in DMEM, containing more L-Tyr, as compared to RPMI. The EPR studies revealed that the effect of curcumin on melanogenesis in RPMI-incubated cells was not significant, and only in DMEM was curcumin able to inhibit melanogenesis. The effect of curcumin was only quantitative, as it did not switch eumelanogenesis towards pheomelanogenesis under any conditions. Interestingly, we observed elevation of production of hydrogen peroxide in DMEM-incubated cells, in parallel to the facilitation of melanogenesis. Curcumin significantly but transiently intensified the already pronounced generation of H2O2 in DMEM. We conclude that the quantitative effect of curcumin on melanogenesis in melanoma is intricate. It depends on the basic melanogenetic efficiency of the cells, and can be observed only in strongly pigmented cells. Qualitatively, curcumin does not switch melanogenesis towards pheomelanogenesis, either in strongly, or in weakly melanized melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398276     DOI: 10.1007/s00403-014-1523-1

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  The effects of vitamin B6 compounds on cell proliferation and melanogenesis in B16F10 melanoma cells.

Authors:  Taisuke Matsuo; Aki Fujiwara; Kazuhiro Nakamura; Yasuyuki Sadzuka
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

2.  Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells.

Authors:  Shilpi Goenka; Francis Johnson; Sanford R Simon
Journal:  Biomolecules       Date:  2021-04-30

3.  Membrane-Associated Transporter Protein (MATP) Regulates Melanosomal pH and Influences Tyrosinase Activity.

Authors:  Bum-Ho Bin; Jinhyuk Bhin; Seung Ha Yang; Misun Shin; Yeon-Ju Nam; Dong-Hwa Choi; Dong Wook Shin; Ai-Young Lee; Daehee Hwang; Eun-Gyung Cho; Tae Ryong Lee
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

Review 4.  The role of transcription factor Nrf2 in skin cells metabolism.

Authors:  Agnieszka Gęgotek; Elżbieta Skrzydlewska
Journal:  Arch Dermatol Res       Date:  2015-02-24       Impact factor: 3.017

5.  Bifunctional effects of O-methylated flavones from Scutellaria baicalensis Georgi on melanocytes: Inhibition of melanin production and intracellular melanosome transport.

Authors:  Michiko Kudo; Kumiko Kobayashi-Nakamura; Kentaro Tsuji-Naito
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

6.  Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy.

Authors:  Diana Tudor; Iuliana Nenu; Gabriela Adriana Filip; Diana Olteanu; Mihai Cenariu; Flaviu Tabaran; Rodica Mariana Ion; Lucian Gligor; Ioana Baldea
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

7.  Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets.

Authors:  Eumorphia G Konstantakou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Zoi I Litou; Ourania A Konstandi; Aikaterini F Giannopoulou; Ema Anastasiadou; Gerassimos E Voutsinas; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

8.  Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.

Authors:  Valentin-Florian Rauca; Emilia Licarete; Lavinia Luput; Alina Sesarman; Laura Patras; Paul Bulzu; Elena Rakosy-Tican; Manuela Banciu
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

9.  LEF-1 Regulates Tyrosinase Gene Transcription In Vitro.

Authors:  Xueping Wang; Yalan Liu; Hongsheng Chen; Lingyun Mei; Chufeng He; Lu Jiang; Zhijie Niu; Jie Sun; Hunjin Luo; Jiada Li; Yong Feng
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

10.  Efficient Percutaneous Delivery of the Antimelanogenic Agent Glabridin Using Cationic Amphiphilic Chitosan Micelles.

Authors:  Haruyoshi Seino; Yukari Arai; Norio Nagao; Noriyasu Ozawa; Kazuhiko Hamada
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.